Navigation Links
Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
Date:4/27/2010

o know that pharmaceutical companies are marketing their drugs only for uses approved by the FDA and that their doctors' judgment has not been affected by misinformation from a pharmaceutical company trying to boost revenues."

In addition to the civil settlement agreement, resolution of the matter includes a  Corporate Integrity Agreement (CIA) between AstraZeneca and the Office of Inspector General of the Department of Health and Human Services. The five-year CIA requires, among other things, that a board of directors committee annually review the company's compliance program and certify its effectiveness; that certain managers annually certify that their departments or functional areas are compliant; that AstraZeneca send doctors a letter notifying them about the settlement; and that the company post on its website information about payments to doctors, such as honoraria, travel or lodging.  AstraZeneca is subject to exclusion from Federal health care programs, including Medicare and Medicaid, for a material breach of the CIA and subject to monetary penalties for less significant breaches.

"As a result of this Corporate Integrity Agreement, the actions of AstraZeneca will be more transparent, its Board of Directors held more accountable, and the names of physicians receiving payments will be disclosed -- all leading to better protection for patients," said Department of Health and Human Services Inspector General Daniel R. Levinson.

The government's investigation was triggered by a whistleblower lawsuit filed under the FCA's qui tam provisions in the Eastern District of Pennsylvania.  As part of today's resolution, James Wetta, the whistleblower in that action, will receive more than $45 million from the federal share of the
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- The Physician-Patient Alliance for Health & Safety ... "Surviving Your Hospital Stay: Physician-Patient Alliance for Health ... A sentence was omitted from the release. ... is a member of the National Coalition to Promote ... the National Coalition to Promote Continuous Monitoring of Patients ...
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 1 The Center for,Translational Molecular Medicine (CTMM) ... and development of new techniques for,the diagnosis and ... nine,projects will receive research funding amounting to a ... a broad spectrum of small and,medium-sized enterprises, major ...
... warmer,the American Heartworm Society (AHS) wants every pet owner ... risk it carries for pets., Although the risk ... mosquito population increases, the AHS recommends year-round,prevention for both ... pet owners will have their pets protected when they ...
Cached Medicine Technology:Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease 2Mosquito Season Approaching: American Heartworm Society Reminds Pet Owners of Risk 2
(Date:7/31/2015)... ... July 31, 2015 , ... ... a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies ... long-term and post-acute care providers understand the benefits of using medication management ...
(Date:7/31/2015)... ... July 31, 2015 , ... ZH Healthcare announces a new cloud based ... HITaaS? Health IT as a Service (HITaaS) is a Healthcare dedicated cloud based service ... , HITaaS manages all aspects of infrastructure, security, runtime, middleware, OS, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Physical therapy for knee osteoarthritis ... quality of life. It keeps the patient from doing what they want or need to ... a hard time using the stairs. The patient's exercise regime may be limited by the ...
(Date:7/31/2015)... ... July 31, 2015 , ... New Energy Works Timberframers invites ... in McMinnville, Oregon August 15th, 2015 from 9am – 12pm. Timber frame raisings ... day for the entire community as the culmination of months of effort, planning, fundraising, ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The ... Rep. Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From ... physician and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding ...
Breaking Medicine News(10 mins):Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3
... Investigation into allergic reactions, deaths related to blood thinner ... Healthcare Corp., the pharmaceutical company at the center of ... that it was recalling any remaining multi-dose vials of ... company also said it was recalling its Hep-Lock heparin ...
... Directors of,Belden (NYSE: BDC ) has appointed Mary ... Committee of the board. Ms. McLeod, age 51, is ... a post she has held,since April 2007. Pfizer (NYSE: ... company. Prior to joining Pfizer, Ms. McLeod,was an executive ...
... from the ADVANCE Study, involving 11,140 high-risk patients with ... risk of death among those patients receiving aggressive treatment ... from the 10,251 patient ACCORD trial which halted the ... early because a data review revealed that patients who ...
... a Growth Driver, BEIJING, Feb. 28 /Xinhua-PRNewswire-FirstCall/ ... CMED ), a leading China-based,medical device company that ... and high intensity focused ultrasound tumor,therapy system, today ... ended December 31, 2007 ("3Q FY2007"). The Company,s ...
... Safe Limits on Nurses, Patient Assignments, Prohibits, Mandatory Overtime and Includes ... ... BOSTON, Feb. 28 The 125-member Coalition to Protect,Massachusetts Patients ... to approve a bill to guarantee safe RN staffing in,all Massachusetts ...
... health care needs, such as autism, attention deficit hyperactivity ... is federally recommended and that there are vast state-to-state ... the national and state level has been available to ... , "Parents of children with special health care needs ...
Cached Medicine News:Health News:Baxter Recalls Rest of Heparin Products 2Health News:Baxter Recalls Rest of Heparin Products 3Health News:Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors 2Health News:ADVANCE diabetes trial results confirm no evidence of safety risk 2Health News:ADVANCE diabetes trial results confirm no evidence of safety risk 3Health News:China Medical Technologies Reports Third Quarter Financial Results 2Health News:China Medical Technologies Reports Third Quarter Financial Results 3Health News:China Medical Technologies Reports Third Quarter Financial Results 4Health News:China Medical Technologies Reports Third Quarter Financial Results 5Health News:China Medical Technologies Reports Third Quarter Financial Results 6Health News:China Medical Technologies Reports Third Quarter Financial Results 7Health News:China Medical Technologies Reports Third Quarter Financial Results 8Health News:China Medical Technologies Reports Third Quarter Financial Results 9Health News:China Medical Technologies Reports Third Quarter Financial Results 10Health News:China Medical Technologies Reports Third Quarter Financial Results 11Health News:China Medical Technologies Reports Third Quarter Financial Results 12Health News:Patient Safety Act is Approved by Public Health Committee 2Health News:Patient Safety Act is Approved by Public Health Committee 3Health News:New child health data show state-to-state differences in quality of care 2
Hosford foreign body spud 4 3/4 inches, gouge blade 1 x 7 mm rounded tip, angled to left....
Foreign body spud angled, lightly rounded tip....
... Manufactured from premium high ... high oxygen permeability. Standard ... Recommended for the following ... and abrasions. bullous keratopathy, ...
Guthrie fixation hook, sharp double prongs....
Medicine Products: